These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6385623)

  • 21. The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer.
    Pitot HC; Goldsworthy T; Moran S
    J Supramol Struct Cell Biochem; 1981; 17(2):133-46. PubMed ID: 7033553
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of Syrian hamster embryo and BALB/c 3T3 cell transformation for assessing the carcinogenic potential of chemicals.
    LeBoeuf RA; Kerckaert KA; Aardema MJ; Isfort RJ
    IARC Sci Publ; 1999; (146):409-25. PubMed ID: 10353397
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal tumors and other lesions in rats following a single intravenous injection of daunomycin.
    Sternberg SS; Philips FS; Cronin AP
    Cancer Res; 1972 May; 32(5):1029-36. PubMed ID: 5017735
    [No Abstract]   [Full Text] [Related]  

  • 24. Neoplastic transformation of Syrian hamster epidermal cells in vitro.
    Sina JF; Bradley MO; O'Brien TG
    Cancer Res; 1982 Oct; 42(10):4116-23. PubMed ID: 7105008
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo carcinogenesis of 4-nitroquinoline 1-oxide and related compounds.
    Ito N
    Carcinog Compr Surv; 1981; 6():117-53. PubMed ID: 6786743
    [No Abstract]   [Full Text] [Related]  

  • 26. Carcinogenic effect of nitrosomorpholine administered in the drinking water to Syrian golden hamsters.
    Ketkar MB; Holste J; Preussmann R; Althoff J
    Cancer Lett; 1983 Jan; 17(3):333-8. PubMed ID: 6831389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited in vivo bioassays.
    Mazue G; Gouy D; Remandet B; Garbay JM
    Ann N Y Acad Sci; 1983; 407():374-86. PubMed ID: 6136250
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor promoters and cell transformation.
    Diamond L
    Pharmacol Ther; 1984; 26(1):89-145. PubMed ID: 6398446
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic tumours and other chronic liver changes in rats following a single oral administration of aflatoxin.
    Carnaghan RB
    Br J Cancer; 1967 Dec; 21(4):811-4. PubMed ID: 6074701
    [No Abstract]   [Full Text] [Related]  

  • 30. Cell proliferation and promoting action in skin carcinogenesis.
    Raick AN
    Cancer Res; 1974 May; 34(5):920-6. PubMed ID: 4842806
    [No Abstract]   [Full Text] [Related]  

  • 31. [The blastomogenic effect of the nitrosamines--DMNA, DENA, and MNU on Djungarian hamsters].
    Vasil'eva NN; Sokova OI
    Vopr Onkol; 1971; 17(4):58-63. PubMed ID: 5564880
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new animal for experimental oncologic research--the Dzhungarian hamster].
    Pogosiants EE; Sokova OI; Prigozhina EL
    Vopr Onkol; 1970; 16(3):90-8. PubMed ID: 4316797
    [No Abstract]   [Full Text] [Related]  

  • 33. The study of tumor promotion in a cell culture model for mouse skin--a tissue that exhibits multistage carcinogenesis in vivo.
    Yuspa SH; Hennings H; Kulesz-Martin M; Lichti U
    Carcinog Compr Surv; 1982; 7():217-30. PubMed ID: 6121622
    [No Abstract]   [Full Text] [Related]  

  • 34. Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice.
    Cohen SM; Ertürk E; Bryan GT
    Cancer Res; 1970 Apr; 30(4):906-12. PubMed ID: 4324549
    [No Abstract]   [Full Text] [Related]  

  • 35. Nitrosoazetidine--a potent carcinogen of low toxicity.
    Lijinsky W; Lee KY; Tomatis L; Buutler WH
    Naturwissenschaften; 1967 Oct; 54(19):518. PubMed ID: 5586158
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of partial hepatectomy on tumor incidence in BALB-c mice treated with urethan.
    Lane M; Liebelt A; Calvert J; Liebelt RA
    Cancer Res; 1970 Jun; 30(6):1812-6. PubMed ID: 4318705
    [No Abstract]   [Full Text] [Related]  

  • 37. The Syrian hamster embryo cells transformation assay identifies efficiently nongenotoxic carcinogens, and can contribute to alternative, integrated testing strategies.
    Benigni R; Bossa C; Tcheremenskaia O; Battistelli CL; Giuliani A
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Feb; 779():35-8. PubMed ID: 25813724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinogenicity of sterigmatocystin to rat skin.
    Purchase IF; Van der Watt JJ
    Toxicol Appl Pharmacol; 1973 Oct; 26(2):274-81. PubMed ID: 4751106
    [No Abstract]   [Full Text] [Related]  

  • 39. Thresholds of carcinogenicity in the ED01 study.
    Andersen ME; Conolly RB; Gaylor DW
    Toxicol Sci; 2003 Aug; 74(2):486-7; author reply 487-8. PubMed ID: 12874369
    [No Abstract]   [Full Text] [Related]  

  • 40. [Activation of oncogenes by chemical modification with carcinogens].
    Hashimoto Y; Shudo K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3354-64. PubMed ID: 3098180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.